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Jigisha PatelAbstract
Background: The purpose and effectiveness of peer review is currently a subject of hot debate, as is the need for
greater openness and transparency in the conduct of clinical trials. Innovations in peer review have focused on the
process of peer review rather than its quality.
Discussion: The aims of peer review are poorly defined, with no evidence that it works and no established way to
provide training. However, despite the lack of evidence for its effectiveness, evidence-based medicine, which
directly informs patient care, depends on the system of peer review. The current system applies the same process
to all fields of research and all study designs. While the volume of available health related information is vast, there
is no consistent means for the lay person to judge its quality or trustworthiness. Some types of research, such as
randomized controlled trials, may lend themselves to a more specialized form of peer review where training and
ongoing appraisal and revalidation is provided to individuals who peer review randomized controlled trials. Any
randomized controlled trial peer reviewed by such a trained peer reviewer could then have a searchable ‘quality
assurance’ symbol attached to the published articles and any published peer reviewer reports, thereby providing
some guidance to the lay person seeking to inform themselves about their own health or medical treatment.
Summary: Specialization, training and ongoing appraisal and revalidation in peer review, coupled with a quality
assurance symbol for the lay person, could address some of the current limitations of peer review for randomized
controlled trials.
Keywords: Peer review, Evidence based medicine, EBM, Randomized controlled trials, RCT, Clinical training,
Medical education, Reporting guidelines, CONSORTBackground
A brief history of trial reporting and peer review
‘Better have them all removed now.’ That was the advice
I received in the early 1990s when my pain free un-
erupted wisdom teeth first came to the notice of a sur-
geon. He was emphatic that I would suffer complications
in the future if I did not have all four teeth removed
under a general anesthetic. This seemed drastic to me,
but I was given the same advice by two health profes-
sionals and it was with trepidation that I questioned
their advice. At the time, ‘Evidence-Based Medicine’
which proposed the use of scientific evidence to inform
clinical decision making was still a novel idea [1] and theCorrespondence: Jigisha.patel@biomedcentral.com
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unless otherwise stated.Cochrane Collaboration [2], aimed at facilitating up-to-
date systematic reviews of randomized controlled trials,
had recently been founded.
I decided to search for the evidence. My only source
of information was a medical library where I could iden-
tify and photo-copy relevant looking articles or get cop-
ies via an ‘inter-library loan’. I did not find any useful
information, but I decided against the procedure on the
basis that the risk of a general anesthetic and a stay in
hospital seemed to me to completely outweigh any benefit
of having four perfectly healthy pain-free teeth removed.
A short time later, when I was a junior doctor, a sub-
group analysis of the diabetic patients who took part
in the original ‘4S study’ [3], reported that simvastatin
treatment improved morbidity and mortality in patients
with diabetes [4]. At the time, my peers and I took foris is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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were published must have chosen the best people quali-
fied to peer review and the peer reviewers must have
done a competent job. The reported findings were com-
pelling enough to have a profound effect on the care re-
ceived by patients with diabetes.
These experiences not only illustrate the barriers to
information I faced as a patient, but the power of indi-
vidual clinical trials to directly influence treatment deci-
sions for individual patients and the blind faith I and my
peers had in a system whereby publication in a peer
reviewed journal gave the reported results the status of
‘the evidence’ and, therefore, the ‘Truth’.
While my faith in the publication process was naïve
and misplaced, flaws in the way RCTs were conducted
and reported were recognized and initiatives were
underway to address these concerns. These culminated
in the Consolidated Standards of Reporting Trials
(CONSORT) statement [5] which aims to specify in detail
how RCTs should be reported to improve transparency
and help peer reviewers and readers make informed
judgments about clinical trials. Since then a number of
reporting guidelines for other types of clinical studies have
been developed [6].
While reporting guidelines aimed to address how in-
dividual trials were reported, there were also concerns
about how far only positive or favorable findings were pub-
lished while those with less exciting, favorable or inclusive
findings were not (publishing bias). In 2005, the Inter-
national Committee of Medical Journal Editors (ICMJE)
published a statement announcing that its member jour-
nals would adopt compulsory trial registration as journal
policy [7]. The aim was to register the existence of all clin-
ical trials so that they became part of the public record.
Recently, in light of ongoing concerns about publica-
tion bias and the suppression of unfavorable results, the
All Trials campaign [8] was launched which calls for the
registering of all clinical trials and availability of all data
for treatments in current use.
Meanwhile, running parallel with this, the world of
peer review, was undergoing a revolution. Most defini-
tions of peer review include a description of a process of
scrutiny by independent experts or peers in the same
field [9,10]. For peer-review journals this process in-
volves sending submitted manuscripts to two or more
people deemed to be knowledgeable enough in the field
of the manuscript to judge its suitability for publication
in that journal.
Flaws with the common single blind peer review sys-
tem (where the reviewers know who the authors are, but
the authors do not know who the reviewers are) were
recognized [11] and there were experiments with double
blind peer review to attempt to address this as well as in
open peer review where the identity of reviewers andauthors is known to all. While closed peer review did
not appear to improve the quality of peer review [12],
open peer review did appear to be feasible without
undermining the quality of peer reviewer reports [13]
and was first adopted by the British Medical Journal
(BMJ) in 1999 [14].
The novel idea of an ‘Open Access’ journal, where all
published research is freely available without subscrip-
tion, began to emerge and although it was met by fer-
ocious opposition from publishers [15], BioMed Central
[16], the first completely online open access publisher
was founded in 2000, followed, in 2006, by the launch of
PLoS One [17].
The number of peer reviewed journals has been in-
creasing at a steady rate of 3.5% a year and almost all
are now available online [18]. With online publishing
flourishing and with technical advances that allow com-
ments to be made and shared in real time on a global
stage, the process of traditional peer review, which can
be slow and laborious, has been criticized [19]. New mo-
dels of peer review have emerged and include (Table 1):
re-review opt out [20], post-publication peer review [21],
decoupled peer review [22-24], portable peer review [25],
and collaborative peer review [26,27].
The impetus behind these recent initiatives has been
to reduce delays for authors and reduce burden for re-
viewers. Their focus is on the process of peer review in
terms of how and when it is done, rather than the sub-
stance and quality of peer review itself or expertise of
the peer reviewer.
Discussion
The problem with peer review in medicine
Recent innovations in peer review seem to be driven by
biologists with medical research ‘tagging along’. How-
ever, systems which might help biological research to
thrive, might not necessarily be appropriate for research
that directly influences patient care. There is no agree-
ment on who a ‘peer’ or what ‘peer review’ actually is
[11]. It is not clear what peer review aims to achieve
[28] and no evidence that peer review works [29]. Jour-
nal instructions for peer reviewers [30] and the criteria
for eligibility to peer review are variable (Table 1). There
has been little evaluation of any of the more recent inno-
vations in peer review for any outcomes. Furthermore,
the whole system is based on honesty and trust and, as a
consequence, is not designed to detect fraud.
Despite this, peer review is still seen by researchers as
important and necessary for scientific communication
[31] and publication in a peer reviewed medical journal
is still the only valid or legitimate route to disseminating
clinical research. In 2006, Richard Smith of the BMJ com-
mented that it was, ‘odd that science should be rooted in
belief ’ [11]. In the world of evidence based medicine, it is
Table 1 Models of peer review
Peer review model Examples Available information on peer review
selection criteria
Single blind Reviewers know who the authors are, but authors
do not know who the reviewers are.
The majority of
biomedical journals
Varies from journal to journal. The journal editors
select peer reviewers according to their own
criteria.
Double blind Both the reviewers and authors remain
anonymous
As above
Open peer review Both reviewers and authors are known to each
other





Re-review opt out Authors are able to ‘opt-out’ of re-review after
revisions if reviewers deem the research to be
sound.
BMC Biology: [20] As above, but one referee will usually be selected
from those nominated by the author.
Collaborative peer
review
Peer review includes a stage where the peer
reviewers with or without the editor or authors
take part in real time interactive discussion about
the manuscript and agree a single set of revisions.
Elife [26] A member of a ‘Board of Reviewing Editors’
oversees peer review and usually peer reviews
themselves.
Frontiers [27] Members of the Editorial Board peer review and
use a formal evaluation system
Portable peer
review
Manuscripts which are peer reviewed by one
journal, but rejected on grounds of threshold or
interest are transferred together with their peer
review reports to other journals which have the
scope and threshold to match the manuscript.
This can occur within a publisher or between a
consortium of publishers.




Manuscripts are submitted to a peer reviewing
service which organizes peer review and provides
advice on appropriate journals based on the peer
review reports.
Axios Review [23] Criteria can vary. For example,
Rubriq [24] Rubriq: Peer reviewers must have a terminal
degree in the area of interest, be employed full
time in an accredited research university at the
level of professor, instructor, post doc fellow or
faculty research associate, must be a published
first author or corresponding author in a peer
reviewed academic journal within the last four
years, and have prior experience as a journal peer
reviewer. There is a standardized scorecard.
Peerage of science [22]
Journals can also select manuscripts based on the
peer review reports.
Peerage of science: Peer reviewers select the
manuscripts they wish to review. Peer reviewers
need to be scientists to qualify to peer review.
Peer review reports are reviewed by fellow
reviewers. Only scientists who have published a
peer reviewed scientific article in an established
international journal as first or corresponding
author will be validated as Peers.
Post publication
peer review
Manuscripts undergo initial checks and are
published. Peer reviewers are then invited.
Authors can revise their manuscripts. Revisions are
published. If the manuscript ‘passes’ peer review,
the article is indexed in databases such as Pub
Med, Scopus etc
F1000Research [21] F1000Research: Authors are asked to identify five
potential referees who might be from the peer
review panel. Author suggested referees should
not have collaborated with the authors in the
past five years, be from their own institution, or
be too senior to be likely to undertake such
refereeing (they should ideally have authored at
least one article in the field as the lead author).
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is based is itself based on such precarious foundations
with so many untested assumptions. Today, a junior doc-
tor still relies on faith in the peer review system when
judging a clinical trial and a patient searching, ‘Should I
have my wisdom teeth removed if they don’t hurt?’ would
get more than a million results on Google (search date 12May 2014) with no guidance on the relevance or trust-
worthiness of any of them, leaving them as much in the
dark as I was when I first asked that question. The differ-
ence between now and then is that then, information was
just not available or accessible, and now, there is so much
information available of varying quality that it is impos-
sible to make sense of it all without some specialist
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search for (prophylactic extraction of third molar) and
which sources they can trust (the Cochrane library), the
relevant information can be found easily. According to a
Cochrane review I found [32], there is no evidence ei-
ther way of the benefit of having wisdom teeth removed
if they are asymptomatic. I feel reassured I made the right
decision all those years ago. However, not all clinical ques-
tions can be answered so easily or can afford the luxury of
waiting for a Cochrane systematic review to be done. When
there is no ready-made Cochrane review, a system that pro-
vides some sort of quality check for individual studies
might serve as an important consideration for patients (and
doctors) who need to weigh up, using the available evi-
dence, the risks and benefits of a course of action and make
definitive, time dependent, decisions that could be life
changing.
A UK Parliamentary enquiry on peer review in 2011
[33] concluded that different types of peer review are
suitable for different disciplines and encouraged increased
recognition that peer-review quality is independent of
journal business model. With this in mind, is there a need
to redesign peer review specifically for clinical research
and ensure that this is driven by the clinical community?Training and specialization in peer review
With peer review as a vague and undefined process it is
not surprising that in a survey of peer review conducted
by Sense about Science, 56% of reviewers in a survey
said there was a lack of guidance on how to review and
68% thought formal training would help [31]. Training
and mentoring schemes for peer review have shown
little impact [34-37] and even a decline in peer reviewer
performance with time [38]. It may be that by the time
a researcher has reached the stage in their career when
they start to peer review, it is too late to teach peer review.
Although reporting guidelines have been available for
two decades, many researchers and reviewers still do not
understand what they are or the need for them. This
is further compounded by inconsistent guidance from
journals for authors on how to use reporting guidelines
[30] and a lack of awareness of how they can improve
the reporting of RCTs [39] and, thereby, aid peer review.
There are misunderstandings about trial registration
and even what constitutes an RCT. There is evidence
that reviewers fail to detect deliberately introduced errors
[34,37] and do not detect deficiencies in reporting methods,
sometimes even suggesting inappropriate revisions [40].
Manuscripts reporting poorly conducted clinical research
get published in peer reviewed journals and their
findings inform systematic reviews, which in turn could also
be poorly conducted and reported. These systematic reviews
have the potential to inform clinical judgments.The need for a concerted effort across disciplines to in-
vestigate the effects of peer review has been recognized
[28], but before the effects can be investigated, the aims of
peer review need to be defined. This is a daunting chal-
lenge if one aim, or a small number of aims, is intended to
fulfill all peer review needs for all fields, specialties and
study designs. A more manageable way may be to intro-
duce specialization into peer review, so that specific fields
can define the purpose and aims of peer review to suit
their own needs and design training to meets those aims.
Since the methodology for conducting and reporting
of RCTs has been defined by the CONSORT statement
[41] which improves the reporting of RCTs [39] and,
thereby, aids the peer review process, peer review of
RCTs lends itself to such specialization. CONSORT
could form the framework for the content of a training
program and help to define the knowledge and skills
that are needed by a given individual to appraise an RCT
critically. Peer reviewers could be taught to spot funda-
mental flaws and be periodically evaluated to make sure
they do, in the same way that any other knowledge or skill
that affects patient care is.
Peer review of RCTs should be recognized as a profes-
sional skill in this way. Every RCT, and its peer review
reports if made public, whether published online, on
paper, open access or subscription only, with open or
closed peer review, or peer reviewed before or after pub-
lication could then have a searchable ‘quality assurance’
symbol (like the ‘kite-mark’ used by the British Standards
Institute [42]) or a word, so that readers know whether a
study was reviewed by at least one appropriately trained
and accredited expert. Such a system could accommodate
all peer review models (Figure 1).
To achieve this, major organizations including medical
schools, medical regulatory and accreditation organi-
zations (such as the General Medical Council and Royal
Colleges in the UK), funding bodies, publishers and jour-
nal editors and lay people need to come to a consensus
on the definition, purpose, standards and training re-
quirements of peer review of RCTs. Training should be-
gin in medical schools and be ongoing.
By recognizing peer review as a professional skill with
measurable standards which are separate from the journal,
publisher or peer review model, peer review is separa-
ted from commercial considerations, peer reviewers get
recognition for their work, and researchers, clinicians and
patients get some indication of quality on which to base
their judgments. Publishers and journals are then free to
innovate while still maintaining consistency of peer review
for RCTS, editors have clear criteria on which to base
their choice of peer reviewer for a given manuscript and a
baseline is set that allows for future research into the ef-
fectiveness of peer review per se and comparative studies
on the effectiveness and quality of emerging innovations.
Figure 1 Interaction of trained RCT peer reviewers with existing peer review models. RCT, randomized controlled trial.
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While innovations in trial reporting and the peer review
process have increased transparency, there has been little
progress in defining the aims and effects or improving the
quality of peer review itself. There is a vast volume of
health information available to the lay person with little or
no guidance on its quality or trustworthiness.
Treatment decisions are based on evidence which is
itself determined by a system for which there is no evi-
dence of effectiveness. Innovations in peer review that
specifically address the quality of peer review and the ex-
pertise of the peer reviewer and provide guidance for lay
people seeking to inform themselves about their own
health related decisions are urgently needed. Formal pro-
fessional training for peer review of RCTs coupled with a
means of identifying RCTs peer reviewed by such trained
experts could address these needs.
The focus of this article has been on peer review of
evidence-based medicine and RCTs in particular because
the consequences of an ill-defined system of peer review
are easily understandable by the scientist and the lay
person alike. However, the purpose of peer review and a
method of training and evaluating peer reviewers could
be defined in a similar way for any other type of study
design or any other field.
Abbreviations
CONSORT: The Consolidated Standards of Reporting Trials; RCT: randomised
controlled trial.
Competing interests
The author is an employee of BioMed Central and Medical Editor of BMC
Medicine. The views expressed in this article are entirely her own.
Authors' contributions
JP is the sole author of this article. She conceived the idea, researched the
background and wrote the manuscript.
Acknowledgements
The author would like to acknowledge Elizabeth Moylan, Biology Editor at
BioMed Central for her detailed comments and suggestions for this
manuscript and the whole Biology and Medical Editors team at BioMed
Central for their general advice and comments.
Received: 22 May 2014 Accepted: 14 July 2014
Published: 30 July 2014
References
1. Evidence-based medicine working group: Evidence-based medicine. A
new approach to teaching the practice of medicine. JAMA 1992,
268:2420–2425.
2. Bero L, Rennie D: The Cochrane Collaboration. Preparing, maintaining,
and disseminating systematic reviews of the effects of health care. JAMA
1995, 274:1935–1938.
3. Scandinavian Simvastatin Survival Study group: Randomised trial of
cholesterol lowering in 4444 patients with coronary heart disease: the
Scandinavian Simvastatin Survival Study (4S). Lancet 1994 344:1383–1389.
4. Pyŏrälä K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson
G: Cholesterol lowering with simvastatin improves prognosis of diabetic
patients with coronary heart disease. A subgroup analysis of the
Scandinavian Simvastatin Survival Study (4S). Diabetes Care 1997,
20:614–620.5. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz
KF, Simel D, Stroup DF: Improving the quality of reporting of randomized
controlled trials. The CONSORT statement. JAMA 1996, 276:637–639.
6. The EQUATOR NETWORK [http://www.equator-network.org/]
7. De Angelis C, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, Kotzin S,
Laine C, Marusic A, Overbeke AJ, Schroeder TV, Sox HC, Van Der Weyden
MB, International Committee of Medical Journal Editors: Clinical trial
registration: a statement from the International Committee of Medical
Journal Editors. N Engl J Med 2004, 351:1250–1251.
8. AllTrials [http://www.alltrials.net/]
9. Wager L, Godlee F, Jefferson T: What is peer review? In How to survive peer
review, Chapter 2. UK: BMJ books; 2002. Chapter 2.
10. Weller AC: Introduction to the editorial review process. In Editorial Peer
Review, Its Strengths and Weeknesss, Chapter 1. 2nd edition. USA: Information
Today Inc; 2002, 15.
11. Smith R: Peer review: a flawed process at the heart of science and
journals. J R Soc Med 2006, 99:178–82.
12. van Rooyen S, Godlee F, Evans S, Smith R, Black N: Effect of blinding and
unmasking on the quality of peer review: a randomized trial. JAMA 1998,
280:234–237.
13. van Rooyen S, Godlee F, Evans S, Black N, Smith R: Effect of open peer
review on quality of reviews and on reviewers' recommendations: a
randomised trial. BMJ 1999, 318:23–27.
14. Smith R: Opening up BMJ peer review. BMJ 1999, 318:4.
15. Anthes E, Former NIH Director on Open Access: Harold Varmus: Public
Library of Science. Available at: [http://seedmagazine.com/content/article/
harold_varmus_public_library_of_science/]
16. BioMed Central [http://www.biomedcentral.com/]
17. PloS One [http://www.plosone.org/]
18. Ware M, Mabe M: The STM report. An Overview of Scientific and Scholarly
Journal Publishing. UK: International Association of Scientific, Technical and
Medical Publishers; 2012: 23-24.
19. Is Peer Review Broken? [http://www.biomedcentral.com/biome/video-is-
peer-review-broken/]
20. Robertson M: Re-review opt out and painless publishing. BMC Biology
2013, 11:18.
21. 21 F1000 Research [http://f1000research.com/author-guidelines]
22. Peerage of Science [http://www.peerageofscience.org/]
23. Axious Review [http://axiosreview.org/the-process/]
24. Rubriq [http://www.rubriq.com/]
25. BioMed Central transfers [http://www.biomedcentral.com/authors/transferfaq]
26. eLife [http://elifesciences.org/about#process]
27. Frontiers [http://www.frontiersin.org/about/reviewsystem]
28. Jefferson TO, Alderson P, Wager E, Davidoff F: Effects of editorial peer
review: a systematic review. JAMA 2002, 287:2784–2786.
29. Jefferson T, Rudin M, Brodney Folse S, Davidoff F: Editorial peer review for
improving the quality of reports of biomedical studies. Cochrane
Database Syst Rev 2007, 18:MR000016.
30. Hirst A, Altman DG: Are peer reviewers encouraged to use reporting
guidelines? A survey of 116 health research journals. PloS One
7:e35621.
31. Mulligan A, Hall L, Raphael E: Peer review in a changing world: an
international study measuring the attitudes of researchers. JASIS&T 2013,
64:132–161.
32. Mettes TD, Ghaeminia H, Nienhuijs ME, Perry J, van der Sanden WJ,
Plasschaert A: Surgical removal versus retention for the management of
asymptomatic impacted wisdom teeth. Cochrane Database Syst Rev 2012,
13:CD003879.
33. House of Commons Science and Technology Committee: Peer review in
scientific publications. Eight Report of Session 2010-12 UK.
34. Schroter S, Black N, Evans S, Carpenter J, Godlee F, Smith R: Effects of
training on quality of peer review: randomised controlled trial. BMJ 2004,
328:673.
35. Houry D, Green S, Callaham ML: Effects of training on quality of peer
review: randomised controlled trial. BMC Med Educ 2012, 12:83.
36. Callaham ML, Tercier J: The relationship of previous training and
experience of journal peer reviewers to subsequent review quality.
PLoS Med 2007, 4:e40.
37. Schroter S, Black N, Evans S, Godlee F, Osorio L, Smith R: What errors do
peer reviewers detect, and does training improve their ability to detect
them? JR Soc Med 2008, 101:507–514.
Patel BMC Medicine 2014, 12:128 Page 7 of 7
http://www.biomedcentral.com/1741-7015/12/12838. Callaham M, McCulloch C: Longitudinal trends in the performance of
scientific peer reviewers. Ann Emerg Med 2011 57:141–148.
39. Turner L, Shamseer L, Altman DG, Schulz KF, Moher D: Does use of the
CONSORT Statement impact the completeness of reporting of
randomised controlled trials published in medical journals? A Cochrane
review. Syst Rev 2012, 1:60.
40. Hopewell S, Collins GS, Boutron I, Yu LM, Cook J, Shanyinde M, Wharton R,
Shamseer L, Altman DG: Impact of peer review on reports of randomised
trials published in open peer review journals: retrospective before and
after study. BMJ 2014 349:g4145.
41. Schulz KF, Altman DG, Moher D, CONSORT Group: CONSORT 2010
statement: updated guidelines for reporting parallel group randomized
trials. Ann Intern Med 2010, 152:726–732.
42. Bsi Kitemark [http://www.bsigroup.com/en-GB/our-services/product-
certification/kitemark/]
doi:10.1186/s12916-014-0128-z
Cite this article as: Patel: Why training and specialization is needed for
peer review: a case study of peer review for randomized controlled
trials. BMC Medicine 2014 12:128.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
